Clinical Trial Update: Intradiscal rhGDF-5 Phase I/II Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating intradiscal rhGDF-5 for degenerative disc disease has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• rhGDF-5 (recombinant human growth differentiation factor-5)

Snippet

Sponsor: DePuy Spine | Conditions: Degenerative Disc Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-01-27